Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where David Easa is active.

Publication


Featured researches published by David Easa.


Journal of Pediatric Surgery | 1991

Congenital chylothorax and mediastinal neuroblastoma

David Easa; Venkataraman Balaraman; Kenneth Ash; Beverly Thompson; Rodney B. Boychuk

This is the first reported association of congenital chylothorax and mediastinal neuroblastoma in a newborn infant. The infant exhibited features of both congenital and acquired chylothorax. Resolution of the chylothorax occurred following ligation of thoracic duct after failure of conservative management with multiple thoracentesis and chest tube drainage.


Lung | 2004

Lavage administration of dilute surfactant in a piglet model of meconium aspiration.

Joan Meister; Venkataraman Balaraman; Malia Ramirez; Catherine F. T. Uyehara; Jeffrey Killeen; Tercia Ku; Donald A. Person; David Easa

Maldistribution of exogenous surfactant may preclude any clinical response in acute lung injury associated with surfactant dysfunction. Our previous studies have shown the effectiveness of surfactant lavage after homogenous lung injury. The present study utilizes a histologically confirmed non-homogeneous lung injury model induced by saline lung-lavage followed by meconium injected into a mainstem bronchus. Piglets were then treated with Infasurf® or Exosurf® by lavage (I-LAVAGE, n = 7; E-LAVAGE, n = 5) or bolus (I-BOLUS, n = 8; E-BOLUS, n = 5), or went untreated (CONTROL, n = 4). Lavage administration utilized a dilute surfactant (35 ml/kg; 4 mg phospholipid/ml) instilled into the lung, followed by gravity drainage. The retained doses of the respective surfactant in the lavage and bolus groups were similar. Results showed that the surfactant distribution was more uniform in the lavage groups compared to the bolus groups. Significant and consistent increases in PaO2 were observed in the lavage groups compared to the bolus groups and the controls. PaO2 (mmHg) at 240 min posttreatment: I-LAVAGE = 297 ± 54, E-LAVAGE = 280 ± 57; I-BOLUS = 139 ± 31; E-BOLUS = 152 ± 29; C = 119 ± 73 (mean ± SEM). Other improved pulmonary function parameters favored lavage administration. We conclude that better surfactant distribution achieved by lavage administration can be more effective than bolus administration in this type of non-homogeneous lung injury.


Neonatology | 1995

End-Tidal Carbon Monoxide in Newborn Infants: Observations during the 1st Week of Life

Venkataraman Balaraman; Susan Pelke; Stephen DiMauro; Steven Cheung; David K. Stevenson; David Easa

Serial end-tidal carbon monoxide corrected for ambient CO (ETCOc) levels were measured in an ethnically diverse population of 87 normal newborn infants during the first 5 days of life. The results demonstrate a progressive reduction in ETCOc from 1.6 +/- 0.4 to 0.8 +/- 0.2 ppm. These levels were unrelated to ethnicity, but were inversely related to serum bilirubin levels. We conclude that ETCOc is not a useful indicator for predicting the course of transitional hyperbilirubinemia in the normal newborn infant.


Pediatric Research | 1993

Pancuronium does not alter the hemodynamic status of piglets after normoxia or hypoxia.

David Easa; Catherine F. T. Uyehara; Edward L. Stevens; Kuuleialoha C. Finn; Venkataraman Balaraman; Sim Helen

ABSTRACT: Pancuronium is a neuromuscular blocking agent commonly used to eliminate agitation in sick newborn infants requiring mechanical ventilation. Experimental data supporting this method of intervention are controversial, and hemodynamic studies in newborn infants report conflicting results. This study was designed to determine the hemodynamic effects of pancuronium administered under conditions of normoxia, hypoxia, and preexposure to hypoxia in neonatal piglets with normal lungs. After baseline hemodynamic and blood gas measurements were obtained, pancuronium was administered in two i.v. bolus injections of 0.1 mg/kg. Tidal volume and minute ventilation were maintained constant during the experimental procedure by adjusting ventilator settings. Twenty min after pancuronium, no changes from baseline values were found in arterial blood gases, heart rate, cardiac output, mean arterial pressure, systemic vascular resistance, pulmonary artery pressure, pulmonary vascular resistance, central venous pressure, or pulmonary capillary wedge pressure in any of the three conditions studied. In conclusion, pancuronium administered during normoxia, hypoxia, or after preexposure to hypoxia while controlled ventilation is maintained does not alter systemic or pulmonary hemodynamic status of the newborn piglet.


Pediatric Research | 1990

Developmental Changes in Sodium Nitroprusside and Atrial Natriuretic Factor Mediated Relaxation in the Guinea Pig Aorta

Venkataraman Balaraman; L K Kullama; David Easa; Jean E Robillard; Glenn M Hashiro; Kenneth T Nakamura

ABSTRACT: Sodium nitroprusside (SNP), a nonreceptor mediated stimulant of soluble guanylate cyclase, and atrial natriuretic factor, a receptor-dependent stimulator of particulate guanylate cyclase, mediate relaxation responses by increasing intracellular cGMP. This in vitro study was designed to compare the ontogeny of relaxation responses to SNP and atrial natriuretic factor in the guinea pig thoracic aorta. Aortic rings from fetuses at 55-60 d gestation (term = 68 d), 1- to 3-d-old newborn, and 12-wk-old adult Hartley guinea pigs were mounted in an organ bath, bathed in Krebs solution, and connected to a force-displacement transducer to measure isometric tension. Relaxation responses to SNP and atriopeptin III were studied with the vessels at optimal resting tension and after preconstriction with an EC85 concentration of norepinephrine. SNP-mediated relaxation showed a significant increase in sensitivity with development among the three age groups (p < 0.05). Methylene blue, an inhibitor of soluble guanylate cyclase, produced no inhibition of relaxation to SNP in fetal aortae, significantly decreased responses along the straight portion of the concentration-response curve in newborn aortae (p < 0.05), and significantly shifted the concentration-response curve to the right (p < 0.05) in adult aortae; but did not prevent vessels from relaxing almost 100% in any age group. However, atriopeptin III-mediated responses were similar in the three age groups and were unaffected by methylene blue. These results suggest that 1) sensitivity to SNP increases with age from fetal through adult life; 2) relaxation mediated by atriopeptin III is similar during development; 3) methylene blue does not affect SNP mediated relaxation in fetuses but progressively decreases sensitivity to SNP in newborns and adults; and4) methylene blue does not affect atriopeptin III-mediated relaxation in any age group.


Pediatric Pulmonology | 1996

Exogenous surfactant decreases oxygenation in Escherichia coli endotoxin-treated neonatal piglets

Sneha Sood; Venkataraman Balaraman; Kuuleialoha C. Finn; Stephen Y. Wilkerson; Thomas G. Mundie; David Easa

Abnormalities of pulmonary surfactant function have been described in association with the acute respiratory distress syndrome (ARDS). Because gram‐negative sepsis is a common cause of ARDS, we treated neonatal piglets with Escherichia coli endotoxin to create a neonatal ARDS model. We hypothesized that under these conditions administration of exogenous surfactant would improve pulmonary function. Study groups included: control (n = 8), Exosurfk (5 mL/kg. 13.5 mg phospholipid/mL, n = 7), Survantak (4 mL/kg. 25 mg phospholipid/mL, n = 6), and saline (5 mL/kg, n = 6). E. coli endotoxin 12 μg/kg was infused over 30 min and resulted in significant pulmonary and hemodynamic abnormalities, histopathologic evidence of nonhomogeneous lung injury, and elevated protein levels in bronchoalveolar lavage washings. Neither Exosurfk nor Survantak ameliorated the pulmonary effects of endotoxin. Instead, there was a prolonged decrease in arterial oxygen tension (PaO2) and dynamic lung compliance after administration of surfactant and saline. Distribution of a bolus of Exosurfk was uneven throughout the lung. We conclude that in this neonatal piglet model of ARDS, bolus surfactant administration had a detrimental effect on oxygenation and pulmonary function. Pediatr Pulmonol. 1996; 22:376–386.


Critical Care Medicine | 1994

Effect of baseline lung compliance on the subsequent response to positive end-expiratory pressure in ventilated piglets with normal lungs.

Thomas G. Mundie; David Easa; Kuuleialoha C. Finn; Edward L. Stevens; Glenn M Hashiro; Venkataraman Balaraman

Objective: To determine the pulmonary function and hemodynamic effects of incremental positive end‐expiratory pressure in two groups of normal ventilated newborn piglets with different baseline dynamic lung compliance. Design: Prospective, controlled, intervention study. Setting: Animal laboratory. Interventions: One group of piglets (inflation group) was prepared with 3 cm H2O (0.29 kPa) positive end‐expiratory pressure and a maximal lung inflation to increase baseline lung compliance as compared with the other group (noinflation group), prepared by 3 hrs of ventilation at zero end‐expiratory pressure. Both groups were then subjected to a sequence of incremental positive end‐expiratory pressures from 0 to 12 cm H2O (0 to 1.18 kPa) in 2‐cm increments for 15‐min periods at each level followed by a 60‐min recovery period at zero end‐expiratory pressure. Measurements and Main Results: Pulmonary function, hemodynamic and blood gas data were collected at each positive end‐expiratory pressure value and at 15‐min intervals during recovery. Baseline dynamic lung compliance was 5.2 ± 0.3 mL/cm H2O (53.04 ± 3.06 mL/kPa) in the inflation group and 2.5 ±0.1 mL/cm H2O (25.5 ± 1.02 mL/kPa) in the no‐inflation group. No differences were found in any other pulmonary function, hemodynamic or blood gas value at baseline. Incremental positive end‐expiratory pressure resulted in a decrease in dynamic lung compliance and an increase in end‐expiratory lung volume in both groups of piglets; dynamic lung compliance was greater in the inflation group at all times. No differences were found in end‐expiratory lung volume between groups. Hemodynamic changes in both groups of piglets included: decreased cardiac output and increased pulmonary vascular resistance and systemic vascular resistance. The changes in cardiac output (‐23% vs. ‐32%), pulmonary vascular resistance (+53% vs. +95%), and systemic vascular resistance (17% vs. 51%) were less in the inflation group as compared with the noinflation group. Conclusions: Baseline dynamic lung compliance is an important determinant of the subsequent effect of positive end‐expiratory pressure on pulmonary function and hemodynamics in the ventilated piglet with normal lungs. (Crit Care Med 1994; 22:1631–1638)


Journal of Perinatology | 1999

Idiopathic Neonatal Hepatitis Associated With a Fatal Coagulopathy

Mary Elaine Patrinos; John M. Hardman; David Easa; Rosanne C. Harrigan

Idiopathic neonatal hepatitis (INH) remains a diagnosis of exclusion in the neonate with conjugated hyperbilirubinemia. The major diagnostic challenge for the clinician is to distinguish this condition from other treatable liver disorders such as biliary atresia. Although the prognosis varies for the familial and sporadic forms of neonatal hepatitis, a poor outcome is generally distinguished by chronic and progressive liver failure. After careful review of the literature, we were unable to find a case of INH associated with a profound, irreversible coagulopathy. Herein, we present a case with the primary presenting findings of persistent prolongation of the prothrombin time (PT) and hypofibrinogenemia, resulting in a catastrophic intracranial hemorrhage and death.


JAMA Pediatrics | 1994

Gowning does not affect colonization or infection rates in a neonatal intensive care unit

Susan Pelke; Donna Ching; David Easa; Marian E. Melish


American Journal of Respiratory and Critical Care Medicine | 1996

Exogenous surfactants in a piglet model of acute respiratory distress syndrome.

Sneha Sood; Venkataraman Balaraman; Kuuleialoha C. Finn; B. Britton; Catherine F. T. Uyehara; David Easa

Collaboration


Dive into the David Easa's collaboration.

Top Co-Authors

Avatar

Venkataraman Balaraman

Kapiolani Medical Center for Women and Children

View shared research outputs
Top Co-Authors

Avatar

Kuuleialoha C. Finn

Kapiolani Medical Center for Women and Children

View shared research outputs
Top Co-Authors

Avatar

Thomas G. Mundie

Tripler Army Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Edward L. Stevens

Tripler Army Medical Center

View shared research outputs
Top Co-Authors

Avatar

Sneha Sood

Kapiolani Medical Center for Women and Children

View shared research outputs
Top Co-Authors

Avatar

Susan Pelke

Kapiolani Medical Center for Women and Children

View shared research outputs
Top Co-Authors

Avatar

Glenn M Hashiro

Tripler Army Medical Center

View shared research outputs
Top Co-Authors

Avatar

Wayne Takenaka

Kapiolani Medical Center for Women and Children

View shared research outputs
Top Co-Authors

Avatar

Beverly Thompson

Kapiolani Medical Center for Women and Children

View shared research outputs
Researchain Logo
Decentralizing Knowledge